Skip to main content

FDA & Regulatory

Accelerated Approval

Accelerated Approval lets the FDA approve a drug for a serious condition based on a surrogate endpoint reasonably likely to predict clinical benefit, with confirmatory trials required afterward. It speeds patient access but carries the risk of later withdrawal if confirmatory data disappoint.

Category
FDA & Regulatory
BioSniper AIPage evidence connected

Prepared research question

How does Accelerated Approval affect the view of a biotech company in practice?

Run cited research

Traceable citations · Unknowns marked

Accelerated Approval lets the FDA approve a drug for a serious condition based on a surrogate endpoint reasonably likely to predict clinical benefit, with confirmatory trials required afterward. It speeds patient access but carries the risk of later withdrawal if confirmatory data disappoint.

Related terms

From term to thesis rule

Investigate how Accelerated Approval changes a biotech thesis

Define when Accelerated Approval should count, block, or trigger a deeper check; BioSniper will compile that logic against available evidence.